Aohua Endoscopy (688212.SH) released its 2023 annual report. The company achieved operating income of 6 during the reporting period...
According to Zhitong Finance App News, Aohua Endoscopy (688212.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 678 million yuan, an increase of 52.29%; net profit attributable to shareholders of listed companies was 578.544 million yuan, an increase of 167.04% year on year; net profit attributable to shareholders of listed companies deducted non-recurring profit and loss of 444.8896 million yuan, an increase of 361.42% year on year; basic earnings per share were 0.43 yuan/share.
The company's 2023 profit distribution plan is: The company plans to distribute a cash dividend of 0.3 yuan (tax included) per share to all shareholders.
During the reporting period, the company actively laid out marketing networks at home and abroad, broadened coverage of hospitals at all levels, and enhanced brand influence in all aspects. At the same time, the company has further strengthened investment in R&D, actively exploited its business advantages in R&D, technology, quality, etc., continuously refined and upgraded products, continuously provided customers with satisfactory endoscopic solutions, and obtained more clinical recognition, resulting in a 52.29% year-on-year increase in the company's revenue.